Rocket Pharmaceuticals- Warrants (02/09/2026) Other Current Assets

As of the most recent data (June 2026), RCKTW shows a other current assets of $5.8M. That compares with $5.7M in the prior-year period — up 2.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RCKTW's other current assets is now $5.8M (was $5.7M) — a 2.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Rocket Pharmaceuticals- Warrants (02/09/2026) is outperforming or lagging.

Tracking RCKTW's other current assets over time shows whether Rocket Pharmaceuticals- Warrants (02/09/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $5.8M That compares with $5.7M in the prior-year period — up 2.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Rocket Pharmaceuticals- Warrants (02/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $5.8M) with ownership activity and broader fundamentals.

Rocket Pharmaceuticals- Warrants (02/09/2026)'s other current assets is $5.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.